Karem K L, Chatfield S, Kuklin N, Rouse B T
Department of Microbiology, University of Tennessee College of Veterinary Medicine, Knoxville 37996, USA.
Infect Immun. 1995 Dec;63(12):4557-63. doi: 10.1128/iai.63.12.4557-4563.1995.
In this study, we constructed strain KR21 (chi 4550 delta cya delta crp delta asd/pYA292asd(+)-toxC+) and compared it with BRD847 (aroA aroD/pnirB-toxC) for the ability to induce humoral and cellular immunity after a single oral or intravenous immunization in 3- to 4-week-old BALB/c mice. ToxC-specific serum immunoglobulin G (IgG) was detectable in animals orally immunized with either BRD847 or KR21. However, after intravenous immunization, IgG was detected only in BRD847-immunized animals. Measurement of immunoglobin types IgG1 and IgG2a suggests that a Th1 cellular response is prominent after immunizations with either system. ToxC-specific IgA was detected in fecal and vaginal samples of animals immunized orally and intravenously with BRD847, while those immunized with KR21 failed to show fecal or vaginal IgA responses. Delayed-type hypersensitivity was used as a measure of induction of T-cell responses in vivo. Mice immunized either orally or intravenously with BRD847 showed significant ear swelling responses after ToxC injections, while KR21-immunized animals failed to show a cellular response. These data indicate that the aroA aroD/pnirB system holds greater potential for inducing global immunity after a single dose when directly compared with the balanced lethal system (delta cya delta crp delta asd/pYA292asd+).
在本研究中,我们构建了菌株KR21(chi 4550 delta cya delta crp delta asd/pYA292asd(+)-toxC+),并将其与BRD847(aroA aroD/pnirB-toxC)进行比较,以研究在3至4周龄的BALB/c小鼠中单次口服或静脉免疫后诱导体液免疫和细胞免疫的能力。用BRD847或KR21口服免疫的动物中均可检测到ToxC特异性血清免疫球蛋白G(IgG)。然而,静脉免疫后,仅在BRD847免疫的动物中检测到IgG。免疫球蛋白类型IgG1和IgG2a的测量表明,两种免疫体系免疫后均以Th1细胞反应为主。在口服和静脉注射BRD847免疫的动物的粪便和阴道样本中检测到ToxC特异性IgA,而用KR21免疫的动物未显示粪便或阴道IgA反应。迟发型超敏反应用作体内T细胞反应诱导的指标。用BRD847口服或静脉免疫的小鼠在注射ToxC后显示出明显的耳部肿胀反应,而用KR21免疫的动物未显示细胞反应。这些数据表明,与平衡致死系统(delta cya delta crp delta asd/pYA292asd+)直接比较时,aroA aroD/pnirB系统在单次给药后诱导全面免疫方面具有更大的潜力。